These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26956944)

  • 1. Policy analysis for deciding on a malaria vaccine RTS,S in Tanzania.
    Romore I; Njau RJ; Semali I; Mwisongo A; Ba Nguz A; Mshinda H; Tanner M; Abdulla S
    Malar J; 2016 Mar; 15():143. PubMed ID: 26956944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WHO policy development processes for a new vaccine: case study of malaria vaccines.
    Milstien J; Cárdenas V; Cheyne J; Brooks A
    Malar J; 2010 Jun; 9():182. PubMed ID: 20576114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing malaria control policy-making in Kenya, Uganda and Tanzania.
    Mutero CM; Kramer RA; Paul C; Lesser A; Miranda ML; Mboera LE; Kiptui R; Kabatereine N; Ameneshewa B
    Malar J; 2014 Aug; 13():305. PubMed ID: 25107509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug.
    Mubyazi GM; Gonzalez-Block MA
    Malar J; 2005 Oct; 4():51. PubMed ID: 16242017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding the China-Tanzania Malaria Control Project: lessons learned from a multi-stakeholder qualitative study.
    Sun Z; Zhou H; Chen F; Lu S; Liang H; Wan E; Tao Z; Zhao H; Zhou X; Yang F; Wang D; Zhang X
    Front Public Health; 2023; 11():1229675. PubMed ID: 37808986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Country planning for health interventions under development: lessons from the malaria vaccine decision-making framework and implications for other new interventions.
    Brooks A; Ba-Nguz A
    Health Policy Plan; 2012 May; 27 Suppl 2(Suppl 2):ii50-61. PubMed ID: 22513733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National malaria vector control policy: an analysis of the decision to scale-up larviciding in Nigeria.
    Tesfazghi K; Hill J; Jones C; Ranson H; Worrall E
    Health Policy Plan; 2016 Feb; 31(1):91-101. PubMed ID: 26082391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Policy challenges in malaria vaccine introduction.
    Moree M; Ewart S
    Am J Trop Med Hyg; 2004 Aug; 71(2 Suppl):248-52. PubMed ID: 15331844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applied mathematical modelling to inform national malaria policies, strategies and operations in Tanzania.
    Runge M; Molteni F; Mandike R; Snow RW; Lengeler C; Mohamed A; Pothin E
    Malar J; 2020 Mar; 19(1):101. PubMed ID: 32122342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of parental perception of malaria vaccine in Tanzania.
    Romore I; Ali AM; Semali I; Mshinda H; Tanner M; Abdulla S
    Malar J; 2015 Sep; 14():355. PubMed ID: 26383545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opinions of key stakeholders on alternative interventions for malaria control and elimination in Tanzania.
    Finda MF; Christofides N; Lezaun J; Tarimo B; Chaki P; Kelly AH; Kapologwe N; Kazyoba P; Emidi B; Okumu FO
    Malar J; 2020 Apr; 19(1):164. PubMed ID: 32321534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costing RTS,S introduction in Burkina Faso, Ghana, Kenya, Senegal, Tanzania, and Uganda: A generalizable approach drawing on publicly available data.
    Galactionova K; Bertram M; Lauer J; Tediosi F
    Vaccine; 2015 Nov; 33(48):6710-8. PubMed ID: 26518406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stakeholders' opinions and questions regarding the anticipated malaria vaccine in Tanzania.
    Mtenga S; Kimweri A; Romore I; Ali A; Exavery A; Sicuri E; Tanner M; Abdulla S; Lusingu J; Kafuruki S
    Malar J; 2016 Apr; 15():189. PubMed ID: 27048260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction of new vaccines: decision-making process in Bangladesh.
    Uddin J; Sarma H; Bari TI; Koehlmoos TP
    J Health Popul Nutr; 2013 Jun; 31(2):211-7. PubMed ID: 23930339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining Health Research for Development: The perspective of stakeholders from an international health research partnership in Ghana and Tanzania.
    Ward CL; Shaw D; Anane-Sarpong E; Sankoh O; Tanner M; Elger B
    Dev World Bioeth; 2018 Dec; 18(4):331-340. PubMed ID: 28470856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.
    Burchett HE; Mounier-Jack S; Griffiths UK; Biellik R; Ongolo-Zogo P; Chavez E; Sarma H; Uddin J; Konate M; Kitaw Y; Molla M; Wakasiaka S; Gilson L; Mills A
    Health Policy Plan; 2012 May; 27 Suppl 2():ii5-16. PubMed ID: 22513732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective analysis of the change in anti-malarial treatment policy: Peru.
    Williams HA; Vincent-Mark A; Herrera Y; Chang OJ
    Malar J; 2009 Apr; 8():85. PubMed ID: 19400953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.
    Wonodi CB; Privor-Dumm L; Aina M; Pate AM; Reis R; Gadhoke P; Levine OS
    Health Policy Plan; 2012 May; 27 Suppl 2():ii27-38. PubMed ID: 22513730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
    Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
    Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.